15 results
PRE 14A
HLTHQ
Cue Health Inc
11 Apr 24
Preliminary proxy
9:01pm
and a member of the R&D Management Committee at Johnson & Johnson Consumer, Medical Devices and the Pharma R&D organization leadership team.
Dr. Ghaim has served
8-K
EX-99.1
HLTHQ
Cue Health Inc
20 Mar 24
Cue Health Announces Strategic Actions to Position Company for Next Stage
5:28pm
in the commercialization of diagnostics, healthcare regulations and R&D: Dr. Paul Brown, former President and CEO of Roche Molecular Diagnostics, and Dr. Lisa Danzig
8-K
kekf1td
22 Jul 22
Departure of Directors or Certain Officers
4:01pm
10-Q
ey2dru
10 Nov 21
Quarterly report
5:18pm
8-K
EX-99.1
4lqg 2pjqe9qnhs
10 Nov 21
Cue Health Reports Third Quarter 2021 Financial Results
4:03pm
S-1
EX-10.13
m8cr2x2
1 Sep 21
IPO registration
5:02pm
DRSLTR
31f 0xmt9uo
24 May 21
Correspondence regarding draft registration statement
12:00am
DRS/A
EX-10.13
yd08oicbu5dqva
24 May 21
Draft registration statement (amended)
12:00am
UPLOAD
f5md23zy t9oy1jpc
19 May 21
Letter from SEC
12:00am
- Prev
- 1
- Next